Taxpas: Epidemiological and Survival Data in Breast Cancer Patients Treated with a Docetaxel-Based Chemotherapy Regimen in South Africa

Table 2

One-year survival rate.

Subgroup	Number of patients (%)
Total cohort (1632)	1369/1632 (84%)
Early stage breast cancer (989)	927/989 (94%)
Metastatic breast cancer (560)	364/560 (65%)
Stage unknown (85)	78/85 (92%)
Triple-negative breast cancer (232)	187/232 (81%)
Nontriple-negative breast cancer (1400)	1182/1400 (84%)